tirzepatide shot FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Weight Loss Injections |

Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis In patients with type 1 diabetes mellitus, inform them that using JARDIANCE can increase their risk of life-threatening diabetic ketoacidosis and that fatal ketoacidosis has occurred

Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, effectiveness or quality before they are marketed

Many patients use NovoCare ($199/mo intro, $349/mo regular as of Jan 2026) to start treatment while their PA or appeal processes

This allows the consumer to participate in the category without the immediate physical penalty of heaviness. 2

Positive User Feedback Many users report reduced hunger and improved energy

(Appetite